Abbott to Acquire Exact Sciences, a Leader in Large and Fast-Growing Cancer Screening and Precision Oncology Diagnostics Segments

Abbott Abbott Laboratories announced an agreement to acquire Exact Sciences Exact Sciences Corporation, valuing the transaction at about $21 billion. The deal will position Abbott to expand its cancer diagnostics leadership, combining Exact Sciences’ screening and precision oncology portfolio with Abbott’s broader healthcare capabilities. Exact Sciences shareholders will receive $105 per share in cash, and the transaction is expected to be immediately accretive to Abbott’s revenue growth and gross margin.

Key facts

Exact Sciences portfolio

Context

Авторское резюме: Abbott заключил соглашение о покупке Exact Sciences, создавая лидера в ранней диагностике рака и персонализированной онкологии на рынке с двузначным ростом.

more

Urban Milwaukee Urban Milwaukee — 2025-11-20

More News